Predictive and prognostic factors in patients treated by neoadjuvant chemotherapy:: A retrospective study.

被引：0
|
作者：
Chollet, P
Amat, S
Leduc, B
Méry-Mignard, D
Mouret-Reynier, MA
Feillel, V
Bleuse, JP
Curé, H
Dauplat, J
Penault-Llorca, F
机构：
[1] Ctr Jean Perrin, INSERM, U484, Clermont Ferrand, France
[2] Ctr Hosp Gen, Brive La Gaillarde, France
[3] AVENTIS, Paris, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9702
引用
收藏
页码：885S / 885S
页数：1
相关论文
共 50 条
  • [21] Pretreatment Platelet and Hemoglobin Levels Are Neither Predictive Nor Prognostic Variables for Patients With Locally Advanced Cervical Cancer Treated With Neoadjuvant Chemotherapy and Radical Hysterectomy A Retrospective Italian Study
    Gadducci, Angiolo
    Cosio, Stefania
    Zola, Paolo
    Tisi, Giancarlo
    Ferrero, AnnaMaria
    Piovano, Elisa
    Cristofani, Renza
    Greco, Carlo
    Sartori, Enrico
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2010, 20 (08) : 1399 - 1404
  • [22] Prognostic and predictive factors of patients with cancer of unknown origin treated with a paclitaxel-based chemotherapy
    Muñoz, A
    Fuente, N
    Barceló, R
    Rubio, I
    Ferreiro, J
    Vivanco, GL
    MEDICINA CLINICA, 2004, 122 (06): : 216 - 218
  • [23] Predictive and Prognostic Factors in HCC Patients Treated with Sorafenib
    Brunetti, Oronzo
    Gnoni, Antonio
    Licchetta, Antonella
    Longo, Vito
    Calabrese, Angela
    Argentiero, Antonella
    Delcuratolo, Sabina
    Solimando, Antonio Giovanni
    Casadei-Gardini, Andrea
    Silvestris, Nicola
    MEDICINA-LITHUANIA, 2019, 55 (10):
  • [24] Long-term prognostic and predictive factors in 107 stage II/III breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy
    Brain, E
    Garrino, C
    Misset, JL
    Carbonero, IG
    Itzhaki, M
    Cvitkovic, E
    Goldschmidt, E
    Burki, F
    Regensberg, C
    Pappo, E
    Hagipantelli, R
    Musset, M
    BRITISH JOURNAL OF CANCER, 1997, 75 (09) : 1360 - 1367
  • [25] Long-term prognostic and predictive factors in 107 stage II/III breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy
    E Brain
    C Garrino
    J-L Misset
    I Garcia Carbonero
    M Itzhaki
    E Cvitkovic
    E Goldschmidt
    F Burki
    C Regensberg
    E Pappo
    R Hagipantelli
    M Musset
    British Journal of Cancer, 1997, 75 : 1360 - 1367
  • [26] Predictive and Prognostic Roles of Pathological Indicators for Patients with Breast Cancer on Neoadjuvant Chemotherapy
    Li, Xinyan
    Wang, Mozhi
    Wang, Mengshen
    Yu, Xueting
    Guo, Jingyi
    Sun, Tie
    Yao, Litong
    Zhang, Qiang
    Xu, Yingying
    JOURNAL OF BREAST CANCER, 2019, 22 (04) : 497 - 521
  • [27] Predictive Factors of Survival in Patients Treated with Nintedanib: A Multicenter Retrospective Spanish Study
    Cruz, P.
    Gutierrez Sainz, L.
    Antonanzas, M.
    Aguado, C.
    Mielgo, X.
    Cabezon, L.
    Chara, L. E.
    Martinez Moreno, E.
    Lage Alfranca, Y.
    Velastegui, A.
    Sotelo, M.
    Garcia Rueda, A.
    Olmedo, M. E.
    Martinez Recio, S.
    De Castro Carpeno, J.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S671 - S672
  • [28] The predictive and prognostic role of tumoral miRNA expression levels in patients with breast cancer (BC) treated with neoadjuvant chemotherapy (NAC)
    Eralp, Y.
    Keskin, S.
    Gezer, U.
    Tukenmez, M.
    Muslumanoglu, M.
    Dalay, N.
    Disci, R.
    Yavuz, E.
    Igci, A.
    CANCER RESEARCH, 2013, 73
  • [29] PREDICTIVE AND PROGNOSTIC ROLE OF SURVIVIN AND P53 EXPRESSION IN PATIENTS WITH ADVANCED OVARIAN CANCER TREATED WITH NEOADJUVANT CHEMOTHERAPY
    Gasowska-Bodnar, A.
    Bodnar, L.
    Jerzak, M.
    Wcislo, G.
    Cichowicz, M.
    Dabek, A.
    Kozlowski, W.
    Szczylik, C.
    Baranowski, W.
    ANNALS OF ONCOLOGY, 2012, 23 : 323 - 323
  • [30] PREDICTIVE AND PROGNOSTIC VALUE OF MOLECULAR BREAST CANCER SUBCLASSIFICATION IN PATIENTS TREATED WITH NEOADJUVANT ANTHRACYLIN/PACLITAXEL-BASED CHEMOTHERAPY
    Mueller, B. M.
    Darb-Esfahani, S.
    Loibl, S.
    Komor, M.
    Budczies, J.
    Noske, A.
    Weichert, W.
    Denkert, C.
    Dietel, M.
    von Mickwitz, G.
    ANNALS OF ONCOLOGY, 2009, 20 : 57 - 58
12345